Rx-360 names new senior executives
2 December 2022 -

Rx-360, a US-based international pharmaceutical supply chain consortium, announced on Thursday that it has named Ben Mills as its new senior director of operations, Joint Audit Program/Quality and Kristen Farr as senior director of Finance.

Mills has around 30 years of biopharmaceutical experience, having served at BSI, Amgen, and Synergen Biotech.

Farr has over 30 years of financial experience and has served as an executive-level leader of strategy consulting, management consulting and finance teams in corporate, consulting and non-profit environments.

Jim Fries, Rx-360 CEO, said, 'Ben and Kristen are experienced and well-respected professionals with an immense amount of knowledge and passion. As we close out another stellar year for Rx-360, these two new leadership roles will help position the consortium for even greater success moving forward. We couldn't be happier to have Ben and Kristen as a part of our team, helping to further our mission to protect patient safety.'